Diatrizoate Meglumine
Suppliers
Names
[ CAS No. ]:
131-49-7
[ Name ]:
Diatrizoate Meglumine
[Synonym ]:
Megluminamidotrizoat
Diatrizoic Acid Methylglucamine
MFCD00069632
3,5-bis(acetylamino)-2,4,6-triiodobenzoic acid - (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol (1:1)
Meglumin-diazetrizoat
1-deoxy-1-(methylamino)-D-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate
3,5-diacetamido-2,4,6-triiodobenzoic acid,(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, compd. with D-glucitol, 1-deoxy-1-(methylamino)- (1:1)
Diatrizoate methylglucamine
Diatrizoate Meglumine
Hypaque meglumine
Renograffin
Meglumine amidotrizoate
Renografin M-76
Unipaque
Reno M-Dip
3,5-Diacetamido-2,4,6-triiodobenzoic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1)
Angiografin
D-Glucitol, 1-deoxy-1-(methylamino)-, 3,5-bis(acetylamino)-2,4,6-triiodobenzoate (salt)
Renurix
Renografin
Methylglucamine diatrizoate
acide 3,5-bis(acétylamino)-2,4,6-triiodobenzoïque - (2R,3R,4R,5S)-6-(méthylamino)hexane-1,2,3,4,5-pentol (1:1)
3,5-Bis(acetylamino)-2,4,6-triiodbenzolcarbonsäure--(2R,3R,4R,5S)-6-(methylamino)hexan-1,2,3,4,5-pentol(1:1)
N-Methyl-D-glucamine diatrizoate
Amidotrizoate meglumine
3,5-Bis(acetylamino)-2,4,6-triiodobenzoic Acid compd. with 1-Deoxy-1-(methylamino)-D-glucitol (1:1)
Urografin 76
Urovist
EINECS 205-024-7
Cystografin
ioxeol
Meglumin-diatrizoat
meglumine diatriazoate
3,5-bis(acetylamino)-2,4,6-triiodobenzoic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1)
meglumine diatrizoate
Triombrast
Verografin
Chemical & Physical Properties
[ Density]:
1.9465 (estimate)
[ Boiling Point ]:
614.1ºC at 760mmHg
[ Melting Point ]:
189-193° (dec)
[ Molecular Formula ]:
C18H26I3N3O9
[ Molecular Weight ]:
809.127
[ Exact Mass ]:
808.880310
[ PSA ]:
215.66000
[ LogP ]:
1.44700
[ Vapour Pressure ]:
6.19E-16mmHg at 25°C
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- LZ4315000
- CHEMICAL NAME :
- Glucitol, 1-deoxy-1-(methylamino)-, 3,5-diacetamido-2,4,6-triiodobenzoate (salt), D-
- CAS REGISTRY NUMBER :
- 131-49-7
- LAST UPDATED :
- 199710
- DATA ITEMS CITED :
- 9
- MOLECULAR FORMULA :
- C11-H9-I3-N2-O4.C7-H17-N-O5
- MOLECULAR WEIGHT :
- 809.17
- WISWESSER LINE NOTATION :
- 1VMR BI DI FI CVQ EMV1 &Q1YQYQYQYQ1M1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 214 mg/kg
- TOXIC EFFECTS :
- Kidney, Ureter, Bladder - changes in both tubules and glomeruli Kidney, Ureter, Bladder - interstitial nephritis Kidney, Ureter, Bladder - urine volume decreased
- REFERENCE :
- 34ZIAG "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 Volume(issue)/page/year: -,392,1969
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 14565 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AAJRDX AJR, American Journal of Roentgenology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.126- 1976- Volume(issue)/page/year: 142,619,1984
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Parenteral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 44504 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AAJRDX AJR, American Journal of Roentgenology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.126- 1976- Volume(issue)/page/year: 142,619,1984
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 19500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- Volume(issue)/page/year: 26,921,1984
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 21200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,32,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intracerebral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 80 mg/kg
- TOXIC EFFECTS :
- Brain and Coverings - recordings from specific areas of CNS Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- REFERENCE :
- THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 26,595,1971 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 81430 No. of Facilities: 86 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 1252 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 81430 No. of Facilities: 1221 (estimated) No. of Industries: 1 No. of Occupations: 8 No. of Employees: 27048 (estimated) No. of Female Employees: 17626 (estimated)
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ RIDADR ]:
NONH for all modes of transport
[ RTECS ]:
LZ4315000
Articles
Immunopharmacol. Immunotoxicol. 36(2) , 150-7, (2014)
The aim of this study was to determine the immunomodulatory activity of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide in vitro. This compound was used for the synthesis of a series of 5-amino-...
BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)
Immunopharmacol. Immunotoxicol. 37(2) , 148-57, (2015)
5-Amino-3-methyl-4-isoxazolecarboxylic acid hydrazide is a non-cytotoxic synthetic isoxazole derivative with considerable immunomodulatory properties demonstrated in in vitro experiments. The aim of t...